Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C recurrence after liver transplantation.

N Bourgeois1

  • 1Medicosurgical Department of Gastroenterology, Hopital Erasme, ULB, Brussels.

Acta Gastro-Enterologica Belgica
|February 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stable laser-acceleration of high-flux proton beams with plasma collimation.

Nature communications·2025
Same author

Current knowledge and practice of Candida auris screening in France: A nationwide survey from the French Society of Medical Mycology (SFMM).

Journal de mycologie medicale·2024
Same author

All-Optical GeV Electron Bunch Generation in a Laser-Plasma Accelerator via Truncated-Channel Injection.

Physical review letters·2024
Same author

Measurement of the decay of laser-driven linear plasma wakefields.

Physical review. E·2023
Same author

Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent <i>Candida</i> spp. to Triazoles and Amphotericin B and Aspergillus spp. to Caspofungin: Further Assessment of Modal Variability.

Antimicrobial agents and chemotherapy·2021
Same author

Automation and control of laser wakefield accelerators using Bayesian optimization.

Nature communications·2020
Same journal

A rare twist in the abdomen: diagnostic and therapeutic approaches to omental infarction - a case report and literature review.

Acta gastro-enterologica Belgica·2026
Same journal

GLP-1 receptor agonist-associated eosinophilic duodenitis presenting as a bowel obstruction : a case report and literature review.

Acta gastro-enterologica Belgica·2026
Same journal

Ampullary Actinomycosis Mimicking Malignancy: A Case Report and Literature Review.

Acta gastro-enterologica Belgica·2026
Same journal

Recurrent gastrointestinal bleeding after Peptide Receptor Radionuclide Therapy for a small intestine neuroendocrine tumor.

Acta gastro-enterologica Belgica·2026
Same journal

A little known cause of ischemic colitis.

Acta gastro-enterologica Belgica·2026
Same journal

Linaclotide for irritable bowel syndrome with constipation: integrating realworld evidence into the therapeutic puzzle.

Acta gastro-enterologica Belgica·2026
See all related articles

Hepatitis C (HCV) recurrence after liver transplantation (LT) is common. Early antiviral therapy may improve outcomes, but its effectiveness and the impact of immunosuppression require further study.

Area of Science:

  • Hepatology
  • Transplantation Immunology
  • Virology

Background:

  • Hepatitis C virus (HCV)-related cirrhosis is a primary indication for liver transplantation (LT).
  • HCV recurrence post-LT is nearly universal, with a significant progression to cirrhosis within five years.
  • While early survival is comparable to other indications, long-term outcomes for HCV recipients worsen over time.

Purpose of the Study:

  • To review the impact of HCV recurrence on liver transplant outcomes.
  • To explore factors influencing HCV recurrence, including viremia, viral genotype, and immunosuppression.
  • To assess current and potential treatment strategies for post-LT HCV recurrence.

Main Methods:

  • Review of existing literature on HCV recurrence after liver transplantation.

Related Experiment Videos

  • Analysis of factors affecting disease severity and patient survival.
  • Evaluation of therapeutic interventions, including antiviral therapy and retransplantation.

    • Main Results:

    • High post-LT HCV viremia correlates with more severe recurrent liver disease.
    • The role of viral genotype in recurrence remains debated.
    • The impact of immunosuppressive agents, particularly steroids, on HCV recurrence is not fully understood.
    • Retransplantation for recurrent HCV cirrhosis offers a 60% one-year survival rate.

    Conclusions:

    • HCV recurrence significantly impacts long-term liver transplant outcomes.
    • Optimizing immunosuppression and exploring early antiviral interventions are crucial.
    • Further research is needed to clarify the influence of viral genotype and immunosuppression on HCV recurrence and outcomes.